Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (lrrk2)

Eileen Kennedy; Arjan Kortholt; Leah G Helton

Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (lrrk2)

Eileen Kennedy (Uitvinder), Arjan Kortholt (Uitvinder), Leah G Helton (Uitvinder)

Celbiochemie

Onderzoeksoutput

26 Downloads (Pure)

Samenvatting

The present disclosure describes synthetic polypeptides for the inhibition or modulation of the activity of leucine-rich repeat kinase 2 (LRRK2) along with methods of using the same in the treatment of medical conditions, for example neurological diseases or disorders.

Originele taal-2	English
Octrooinummer	WO2021173802
Prioriteitsdatum	25/02/2020
Indieningsdatum	25/02/2021
Status	Published - 2-sep.-2021

Toegang tot document

WO2021173802_A1Final publisher's version, 4,91 MB

Handle.net

Permanente koppeling

Citeer dit

@misc{5e91f0ec4e24427d9401686ff1c48004,

title = "Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (lrrk2)",

abstract = "The present disclosure describes synthetic polypeptides for the inhibition or modulation of the activity of leucine-rich repeat kinase 2 (LRRK2) along with methods of using the same in the treatment of medical conditions, for example neurological diseases or disorders.",

author = "Eileen Kennedy and Arjan Kortholt and Helton, {Leah G}",

year = "2021",

month = sep,

day = "2",

language = "English",

type = "Patent",

note = "WO2021173802",

}

TY - PAT

T1 - Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (lrrk2)

AU - Kennedy, Eileen

AU - Kortholt, Arjan

AU - Helton, Leah G

PY - 2021/9/2

Y1 - 2021/9/2

N2 - The present disclosure describes synthetic polypeptides for the inhibition or modulation of the activity of leucine-rich repeat kinase 2 (LRRK2) along with methods of using the same in the treatment of medical conditions, for example neurological diseases or disorders.

AB - The present disclosure describes synthetic polypeptides for the inhibition or modulation of the activity of leucine-rich repeat kinase 2 (LRRK2) along with methods of using the same in the treatment of medical conditions, for example neurological diseases or disorders.

M3 - Patent

M1 - WO2021173802

Y2 - 2021/02/25

ER -

Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (lrrk2)

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit